Efficacy and Safety of Autologous Hematopoietic Stem Cell Transplantation in Treating Type 1 Diabetes Mellitus

    December 2010 in “ Zhonghua neifenmi daixie zazhi
    Weiqiong Gu, Shouyue Sun, Jing-shu Wei, Jie Hong, Zhengyi Tang, Jianmin Liu, M Kellis, Weiqing Wang, Guang Ning
    Studysummary This study found that autologous nonmyeloablative hematopoietic stem cell transplantation may help some newly-onset type 1 diabetes patients become insulin-free, although gastrointestinal and other mild side effects were observed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →